Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness

Velligan, Dawn I, Sajatovic, Martha, Hatch, Ainslie, Kramata, Pavel, Docherty, John·2017·Patient Preference and Adherence

Cited by (332)

Items 201–300 of 332

  1. Predictors of persistence and adherence to deutetrabenazine among patients with Huntington disease or tardive dyskinesia.
    Daniel O. Claassen, Rajeev Ayyagari, Viviana García-Horton, Su Zhang, Sam Leo · 2023 · PubMed Central
  2. Association Between Persistence with Oral Atypical Antipsychotic Medications and Hospital and Emergency Department Utilization in Medicaid Patients with Schizophrenia
    Kristin Richards, Michael T. Johnsrud, Christopher Zacker, Rahul Sasané · 2024 · Patient Preference and Adherence
  3. Research on the Application of Virtual Reality Interventions in Medicine
    Yuxiang Huang · 2024 · Asia-Pacific Conference on Software Engineering, Social Network Analysis and Intelligent Computing (SSAIC)
  4. Adherence with Medication Treatment in Psychiatric Disorders
    Yumi Aoki, Hiroyoshi Takeuchi, Koichiro Watanabe, Allan Tasman · 2024 · Springer eBooks
  5. The relationship between insight and coping attitudes in bipolar disorder patients
    Kübra Tohumcu, Döndü Çuhadar · 2024 · Psychology Health & Medicine
  6. Head-to-Head Comparison of UHPLC-MS/MS and Alinity C for Plasma Analysis of Risperidone and Paliperidone
    Francisco José Toja-Camba, Gonzalo Hermelo-Vidal, Carolina Feitosa-Medeiros, María Vidal Millares, María José Durán-Maseda, Anxo Fernández‐Ferreiro, Cristina Mondelo‐García · 2024 · Pharmaceuticals
  7. Substance Use Disorder Among Patients with Primary Mental Illnesses in Southwestern Uganda
    Abel Rubega, Moses Muwanguzi, Rahel Nkola, Alain Favina, Joseph Kirabira, Samuel Maling, Scholastic Ashaba · 2024 · Journal of Dual Diagnosis
  8. Factors associated with dropout at 2 years post-initiation of treatment in the first episode of schizophrenia
    Jebril M. Benelmokhtar, Bonginkosi Chiliza, Lebogang Simon Phahladira, Robin Alexander Emsley, Laila Asmal · 2021 · South African Journal of Psychiatry
  9. Characteristics of Inpatients Prescribed Dopamine Receptor Blocking Agents
    Shaina E. Schwartz, Lauren Dinkla, Jocelyn Pullen, Rachel Bernard, Archana Kumar · 2025 · Psychopharmacology Bulletin
  10. An exploratory analysis of the role of social supports in psychiatric medication discontinuation: results related to family involvement
    Laysha Ostrow, Bevin Croft, Anne Weaver, Sarah Naeger · 2019 · Psychosis
  11. Text Message Reminders for Long-Acting Injectable Antipsychotics in Patients with Schizophrenia Spectrum Disorders
    Christina J. Chen, Wanda Hilliard · 2023 · Journal of the American Psychiatric Nurses Association
  12. A Qualitative Investigation of the Experience of Taking Xanomeline and Trospium Chloride for Schizophrenia, Part 2: Perceived Changes in Subjective Quality of Life and Medication Satisfaction
    Peter J. Weiden, Cory D. Saucier, April Mitchell Foster, Amy Claxton, Soumya Chatuvedi, Colin L. Sauder, Kaitlin LaGasse, Sloan Rucker, Kristi Jackson, Stephen R. Marder et al. · 2026 · Schizophrenia Bulletin Open
  13. Assessing the accuracy of 4 generative AI tools to guide dosing of long-acting injectable antipsychotics
    Leah A. Surbaugh, Karen E. Moeller · 2026 · American Journal of Health-System Pharmacy
  14. A Rest Quality Metric Using a Cluster-Based Analysis of Accelerometer Data and Correlation With Digital Medicine Ingestion Data: Algorithm Development
    Zahra Heidary, Jeffrey M. Cochran, Timothy S. Peters-Strickland, Jonathan Knights · 2021 · JMIR Formative Research
  15. Healthcare utilisation and costs associated with adherence to antipsychotics among people living with HIV/AIDS and schizophrenia: a population-based cohort study in British Columbia, Canada
    Sony Subedi, Ni Gusti Ayu Nanditha, Hiwot M. Tafessu, Hasan Nathani, Martin St‐Jean, Julius Elefante, Thomas L. Patterson, William G. Honer, Julio S. G. Montaner, Viviane Dias Lima · 2023 · BMJ Open
  16. A retrospective database study on 2-year weight trajectories in first-episode psychosis
    Yi Chian Chua, Edimansyah Abdin, Charmaine Yu Zheng Tang · 2023 · Frontiers in Psychiatry
  17. Healthcare resource use and costs reduction with aripiprazole once-monthly in schizophrenia: AMBITION, a real-world study
    Vanessa Sánchez‐Gistau, María José Moreno, Susana Gómez-Lus, Antoni Sicras‐Mainar, Benedicto Crespo‐Facorro · 2023 · Frontiers in Psychiatry
  18. Comparative Safety of Long-Acting Injectable Antipsychotics: A Systematic Review and Network Meta-Analysis
    Erasmo Saucedo Uribe, Samuel Enrique Olivares Mundo, R. Garza, Fernando Diaz Gonzalez-Colmenero, L. M. Sanchez, C. Cantu, Martínez Arellano, Yessica Yaneth Herrera Montemayor, P. Morales, S. M. Juarez et al. · 2023 · Psychiatry Investigation
  19. Identifying longitudinal medication adherence patterns of antipsychotic treatments: A real‐world cohort study in Catalonia, Spain
    Marina Fuente‐Moreno, Caitríona Cahir, Valéria Lima Passos, Kathleen Bennett, Caroline A. Walsh, Patricia Hermida‐González, Jorge Peláez de Loño, Maria Eugènia Rey Abella, Luisa Baladón, María Rubio-Valera et al. · 2025 · British Journal of Clinical Pharmacology
  20. Understanding the metacognition and impulsivity issues with clinical and cognitive insight in borderline personality disorder – A cross sectional study
    Rajnish Raj, Aaliya Khanam, Zaid Ahmad Wani, Afifa Afreen, Simranjeet Kour, Ajaz A. Khan, Inaamul Haq · 2025 · Industrial Psychiatry Journal
  21. Factors Associated With Insight Toward Illness in Patients With Bipolar Disorder Type 1 in Manic Episodes
    Ya-Fan Chang, Si‐Sheng Huang · 2025 · ALPHA PSYCHIATRY
  22. Psychiatrists' perceptions of medication adherence among patients with schizophrenia: An international survey
    Shunya Kurokawa, Taishiro Kishimoto, Kuan‐Pin Su, Jane Pei‐Chen Chang, Hui-Chih Chang, Xin Yu, Nuno Rodrigues-Silva, Jimmi Nielsen, Anish Unadkat, David Jonathan Castle et al. · 2019 · Schizophrenia Research
  23. Mental health literacy of the Lebanese population (MHeLLP): a cross-sectional study
    Rim Taleb, Nayla Kassab, Asmaa Ibrahim Kebbe, Nour Kreidieh · 2020 · Journal of Public Mental Health
  24. Can Smartphone Apps Assist People with Serious Mental Illness in Taking Medications as Prescribed?
    Cynthia L. Bianco, Amanda L. Myers, Stephen F. Smagula, Karen L. Fortuna · 2020 · Sleep Medicine Clinics
  25. Medication Adherence, Attitude Towards Medication, and Quality of Life in Outpatients With Neurotic Disorders in Tehran, Iran: A Six-Month Follow-up Study
    Somayeh Arabi Khalilabad, Nooshin Khademoreza, Amirsina Homayooni, Shiva Soraya, Sajjad Effatnejat, Ali Kabir, Fatemeh Hadi, Mohammadreza Shalbafan · 2022 · Iranian Journal of Psychiatry and Clinical Psychology
  26. Jail-Based For-Profit Mental Health Providers and Treatment Engagement After Release
    Lester J. Kern, Erin B. Comartin, Victoria Nelson, Sheryl Pimlott Kubiak · 2024 · Psychiatric Services
  27. Blonanserin patch vs. Other Antipsychotics for Acute Schizophrenia: A Systematic Review of Double-blind, Randomized, Placebo-controlled, Phase 3 Trials in Japan
    Taro Kishi, Reiji Yoshimura, Yuki Matsuda, Kenji Sakuma, Nakao Iwata · 2020 · Pharmacopsychiatry
  28. The “PRE” scale: The assessment of the elementary passively received experiences of schizophrenia
    Massimo Moscarelli, Jung-Yun Min, Alex J. Kopelowicz, Oscar Chavez, Lizzette Gómez-de-Regil, Luis Salvador‐Carulla, María Montes Gamez, Regina Vila‐Badia, Cristina Romero-López-Alberca, Anthony O. Ahmed · 2022 · Schizophrenia Research
  29. Effect Size and Blinding in Lumateperone Trial
    Brittany M. Gouse, Alexander L. Chang, Eric G. Smith · 2020 · JAMA Psychiatry
  30. Depression as a Factor in Nonadherence in Schizophrenia
    Hirofumi Hirakawa, Nobuyoshi Ishii · 2020 · The Journal of Clinical Psychiatry
  31. Psychotic symptomatology and medication adherence in patients with schizophrenia: The mediating effect of awareness of mental disorder
    Alejandra Caqueo‐Urízar, Patricio Mena‐Chamorro, Alfonso Urzúa M, Erika Peroza, Guillaume B. Fond, Laurent Boyer · 2022 · Schizophrenia Research
  32. Peer specialists deliver cognitive behavioral social skills training compared to social skills training and treatment as usual to veterans with serious mental illness: study protocol for a randomized controlled trial
    Chantele Mitchell-Miland, Sharon McCarthy, Matthew Chinman · 2022 · Trials
  33. A Brief Psychoeducation Intervention to Prevent Rehospitalization in Severe Mental Disorder Inpatients
    Núria Riera i Molist, Bruna Riera-Morera, Pere Roura Poch, Josep Manel Santos, Quintí Foguet Boreu · 2022 · The Journal of Nervous and Mental Disease
  34. Effectiveness of an Innovative Nursing Approach Through a Smartphone Application in Promoting Medication Adherence Among Patients with Schizophrenia
    Pornpun Sudjai, Pornpat Hengudomsub, Duangjai Vatanasin, Wetid Pratoomsri · 2023 · Journal of Health Science and Medical Research
  35. Evaluating Risk and Benefit Sensitivity for Cognitive Treatments
    Kianté A. Fernandez, Brian Albert Erickson, Joseph W. Kable, Roy H. Hamilton, John Dominic Medaglia · 2025 · Journal of Cognitive Enhancement
  36. Treatment discontinuation and switching of antipsychotics among adult patients with schizophrenia in the United States
    Rezaul Karim Khandker, Babak Mohit, Eileen Fonseca, Sean Fleming, Malinda Sunnita Tan, Wenying Quan, Traci LeMasters, Jordana K. Schmier · 2025 · Schizophrenia Research
  37. Impact of per diem payment on medical expenditure, service efficiency, and quality of care for patients with mental disorders: an interrupted time series study
    Yuanping Pan, Zhiyong Liu · 2025 · BMC Health Services Research
  38. Intentional Non-Adherence in Schizophrenia: The Influence of Antipsychotics’ Sedative Side-Effects A First-Person Account
    Jensen Gert · 2025 · Schizophrenia Bulletin Open
  39. Advancing Personalized Medicine in Psychiatry: A Descriptive Pilot Study Integrating Pharmacogenetics and Pharmacokinetics in Long-Acting Antipsychotic Treatment
    Almudena Gil-Rodríguez, Sheila Recarey-Rama, María Vidal Millares, Francisco José Toja-Camba, María Tajes, Verónica Prado-Robles, María José Durán-Maseda, Manuela Pérez García, Ana Rodríguez-Viyuela, Patricia Sánchez-Fariña et al. · 2026 · Pharmaceutics
  40. A Clinical Guide to the Problem of Hiding Oral Psychotropic Drugs by Psychiatric Patients
    Narjes Hendouei, Mehran Zarghami, Fatemeh Saghafi, Mahdis Amirifar, Monireh Maham, Ali Farmoudeh · 2019 · Iranian Journal of Psychiatry and Clinical Psychology
  41. Improving Medication Adherence in Psychiatric Patients With a Medication Adherence Program
    Whitney Peterson · 2025 · Journal of the American Psychiatric Nurses Association
  42. Incremental healthcare costs among patients experiencing adverse events on oral antipsychotics: a real-world analysis of U.S. Medicare beneficiaries with schizophrenia
    Christopher Zacker, Justin T. Puckett, Sachin J. Kamal‐Bahl · 2025 · Current Medical Research and Opinion
  43. Positive symptoms and medication adherence in response to oral versus long-acting injectable risperidone in black, latino, and white first-episode psychosis patients
    Derek M. Novacek, Kenneth L. Subotnik, Joseph Ventura, Laurie R. Casaus, Fiona Whelan, Catherine A. Sugar, Keith H. Nuechterlein · 2025 · Schizophrenia Research
  44. Neugestaltung einer Akutpsychiatrie – ein Werkstattbericht
    Daniel Schöttle, Jürgen Gallinat · 2019 · Forensische Psychiatrie Psychologie Kriminologie
  45. Implementation and evaluation of a psychoeducation program in an outpatient mental health center
    Anthony Kramer, Pamela Bjorklund · 2020 · Perspectives In Psychiatric Care
  46. Treatment Compliance Communications Between Patients with Severe Mental Illness and Treating Healthcare Providers: A Retrospective Study of Documentation Using Healthcare Reimbursement Claims and Medical Chart Abstraction
    Carolyn K. Martin, Eleena Koep, John C. White, Angela Belland, Heidi C. Waters, Felicia M. Forma · 2021 · Pragmatic and Observational Research
  47. Cannabis Use in Transplantation
    Jorge Luis Sotelo, Melanie Bilbul · 2022 · Springer eBooks
  48. Treatment of schizophrenia evaluated via the pharmacopsychometric triangle—An integrative approach with emphasis on well-being and functioning
    Pernille Kølbæk, Ole N Mors, Christoph Ulrich Correll, Søren Dinesen Østergaard · 2023 · Schizophrenia
  49. N-Acetylcystein: neue Option zur frühen Bekämpfung von Schizophrenie
    Sven Wasserthal, Christian Kloss, René Hurlemann, Johannes Schultz · 2018 · DNP - Der Neurologe und Psychiater
  50. An exploration of young people's experiences of living with mental illness in Phuket
    Mia Nelson · 2019 · Research Commons (University of Waikato)
  51. KLINIKINIS ATVEJIS: KARBAMAZEPINO SUKELTAS ANTIKONVULSANTŲ HIPERJAUTRUMO SINDROMAS IR AGRANULIOCITOZĖ
    Justina Kučinskaitė, Edgaras Dlugauskas, Sigita Lesinskienė · 2019 · Sveikatos mokslai
  52. Eficácia e tolerabilidade da associação de lítio e ácido valpróico em comparação com a associação de lítio e carbamazepina no tratamento de pacientes jovens com transtorno bipolar tipo I (PROJETO LICAVAL)
    Giovani Missio · 2019
  53. Estudio observacional sobre los efectos del palmitato de paliperidona inyectable mensual sobre la hospitalización y asistencia urgente
    J.M. García, M. Soto Ontoso, Eliana Gómez Padrón, María Rosa Sánchez-Waisen Hernández, Yaiza Rojas Vallejo · 2020 · Psiquiatría Biológica
  54. Rehospitalization Risk of Receptor-Affinity Profile in Antipsychotic Drug Treatment: A Propensity Score Matching Analysis Using a Japanese Employment-Based Health Insurance Database
    Yoshiteru Takekita, Sachie Inoue, Kenji Baba, Tadashi Nosaka · 2020 · Neuropsychiatric Disease and Treatment
  55. Características del insight en la esquizofrenia. Una revisión bibliográfica
    Daniel Sotelo, Verónica Grasso, Gabriela Meloni · 2021 · Vertex Revista Argentina de Psiquiatría
  56. Medication Adherence in Primary Care
    Andrew M. Peterson · 2021 · Springer eBooks
  57. Lifetime Cannabis Use Is Not Associated With Negative Beliefs About Medication in Patients With First Treatment Psychosis
    Priyanthi Borgen Gjerde, Synne W. Steen, Trude Seselie Jahr Vedal, Nils Eiel Steen, Elina Johanna Reponen, Ole A. Andreassen, Vidar Martin Steen, Ingrid S. Melle · 2022 · Frontiers in Psychiatry
  58. Cannabis-Based Medicinal Products in the Management of Emotionally Unstable Personality Disorder (EUPD): A Narrative Review and Case Series
    Waseem Sultan, Anup Mathew, Matthew R. D. Brown, Juan Francisco Galvez-Florez, Guillermo Moreno‐Sanz · 2022 · Brain Sciences
  59. Evaluating the effectiveness of virtual buddy support to improve treatment adherence for patients suffering from schizophrenia in KwaZulu-Natal: a model of care
    Nomhle Mvunelo · 2022
  60. Schizophrenie
    Steffen Moritz, Eva Carolin Krieger, Francesca Bohn, Julia Elmers, Ruth Veckenstedt · 2022 · Psychotherapie: Manuale
  61. A New Approach to Enhancing Engagement in eHealth Applications (Preprint)
    Ingrid A. Oakley-Girvan, John P. Docherty · 2022
  62. MKT+: Ein innovativer Ansatz
    Steffen Moritz, Eva Carolin Krieger, Francesca Bohn, Julia Elmers, Ruth Veckenstedt · 2022 · Psychotherapie: Manuale
  63. Pattern of psychiatric presentation among a population of mentally ill patients at the University of Port Harcourt Teaching Hospital
    Nkporbu AK, Ifeanyi Kalu Oti · 2023 · GSC Advanced Research and Reviews
  64. Psychological barriers and innovations in glaucoma adherence
    Facundo G. Sanchez, Steven L. Mansberger · 2023 · Elsevier eBooks
  65. Nonadherence and reasons of nonadherence to drug regimen among schizophrenic patients at Psychiatric OPD, BSMC & H, Bankura, West Bengal
    Tulika Ghosh, Binapani De · 2023 · International Journal of Advanced Psychiatric Nursing
  66. When a patient wants to stop taking their antipsychotic: Be ‘A SPORT’
    Dina Khoury · 2023 · Current Psychiatry
  67. Clinical and statistical analysis of factors affecting compliance in schizophrenia patients
    Victoria V. Ruzhenkova, of the Ministry of Science and Higher Education of the Russian Federation, Belgorod, Russia, Regional State Budgetary Healthcare Institution ", , Belgorod, Russia, I.S. Khamskaya, Konstantin Yu. Retyunskiy, У. С. Москвитина, Oxana V. Zhigulina, O.V. Novikova · 2023 · Vestnik nevrologii psihiatrii i nejrohirurgii (Bulletin of Neurology Psychiatry and Neurosurgery)
  68. Satisfaction with life as a compliance factor of patients with schizophrenia
    Victoria V. Ruzhenkova, Inna S. Khamskaya, Konstantin Yu. Retyunskiy, Alevtina V. Boeva, Oxana V. Zhigulina · 2023 · Neurology Bulletin
  69. Pattern and Prevalence of Drug Use among a Population of Mentally Ill Patients attending the University of Port Harcourt Teaching Hospital
    Nkporbu AK, Inumanye Nkechi Ojule · 2023 · Addiction Research
  70. Decision: Adherence of patients with schizophrenia to hypothyroidism treatment — R1/PR9
    Shay Gur, Shira Weizman, Haggai Hermesh · 2023 · Cambridge Prisms Global Mental Health
  71. Recommendation: Adherence of patients with schizophrenia to hypothyroidism treatment — R1/PR8
    2023 · Cambridge Prisms Global Mental Health
  72. Review: Adherence of patients with schizophrenia to hypothyroidism treatment — R1/PR7
    2023 · Cambridge Prisms Global Mental Health
  73. Author comment: Adherence of patients with schizophrenia to hypothyroidism treatment — R1/PR6
    Shay Gur · 2023 · Cambridge Prisms Global Mental Health
  74. Decision: Adherence of patients with schizophrenia to hypothyroidism treatment — R0/PR5
    Shay Gur, Shira Weizman, Haggai Hermesh · 2023 · Cambridge Prisms Global Mental Health
  75. Review: Adherence of patients with schizophrenia to hypothyroidism treatment — R0/PR3
    2023 · Cambridge Prisms Global Mental Health
  76. Recommendation: Adherence of patients with schizophrenia to hypothyroidism treatment — R0/PR4
    2023 · Cambridge Prisms Global Mental Health
  77. Review: Adherence of patients with schizophrenia to hypothyroidism treatment — R0/PR2
    2023 · Cambridge Prisms Global Mental Health
  78. Author comment: Adherence of patients with schizophrenia to hypothyroidism treatment — R0/PR1
    Shay Gur · 2023 · Cambridge Prisms Global Mental Health
  79. Insights in social psychiatry and psychiatric rehabilitation: 2022
    2024 · Frontiers research topics
  80. Treatment Adherence
    Lara N. Traeger, Zeba N. Ahmad, John B. Herman, Theodore A. Stern · 2024 · Elsevier eBooks
  81. The effectiveness of psychoeducation by health workers at primary health center on medication adherence for people with schizophrenia
    Warih Andan Puspitosari, Virzi Aliyyah Rahma · 2024 · AIP conference proceedings
  82. Psychopharmacological Treatment of Schizophrenia
    Nirmal Singh, Suhas Ganesh, Deepak Cyril D’Souza · 2024 · Elsevier eBooks
  83. Schizophrenic patient’s preference for long-acting injectable antipsychotics in Saudi Arabia
    Khalaf Aljumah, Ibrahim Abdulaziz Al-Zaagi, Ahmad Almutairi, N. Alzaidi, Abdullah Alduraihim, Abdullah Alhwaitan, Sheraz Ali · 2024 · Journal of Medicine and Health Studies
  84. The effects of life review-based collage book making on psychosocial functioning and discrepancy between patients' and hospital staff's perception of daily functioning in long-term hospitalized patients with schizophrenia: A randomized controlled trial
    Fumiko Kaneko, Kazumi Ueno, Rei Hirasawa, Kazuya Saita, Hitoshi Okamura · 2024 · Archives of Psychiatric Nursing
  85. Treatment Adherence
    Lara N. Traeger, Zeba N. Ahmad, John B. Herman, Theodore A. Stern · 2024 · Elsevier eBooks
  86. Is there a relationship between psychiatrist’s clinical assessment of medication non-adherence and treatment outcomes? Implications for practice
    Graham S. Danzer, David S. Sugarbaker, Adriano Zanello, S.L. Barkin, Doug Cort · 2024 · BMC Psychiatry
  87. Barrieren bei der Implementierung pharmakogenetischer Testungen in der Psychiatrie in Deutschland – Ergebnisse aus der FACT-PGx Studie
    Martina Hahn, Amelie Merle Frantz, Andreas Philipp Eckert, Andreas Reif · 2025 · Nervenheilkunde
  88. Initiation of antipsychotic medication among refugees, non-refugee migrants, second-generation migrants, and Swedish-born adults with incident non-affective psychotic disorders
    Daniela Mellin, Ellenor Mittendorfer‐Rutz, Christopher Jamil de Montgomery, Alexis E. Cullen, Heidi T. Taipale · 2025 · Social Psychiatry and Psychiatric Epidemiology
  89. Malingering in Inpatient Psychiatric Units: Who, When, What, and How To Address It?
    Curtis Austin, Chandrika Shankar, Stephen H. Dinwiddie · 2025 · Psychiatric Annals
  90. Virtual nurse support to enhance antipsychotic adherence in schizophrenia: A South African perspective
    Yasmeen Thandar, Nomhle Mvunelo, Singh Deepak, Firoza Haffejee · 2025 · South African Journal of Psychiatry
  91. Understanding attitudes towards psychiatric medications: a comparative study of patients, healthcare professionals, and general population perspectives
    Seda Yavuz, Yavuz Yılmaz, Erdi Bahadır · 2025 · European Journal of Clinical Pharmacology
  92. The Impact of Community‐Level Social and Economic Factors on Healthcare Access Among Individuals With Mental Illness
    J Phillips, Amy Blank Wilson, Todd M. Jensen, Steven C. Marcus, David Ansong, Rainier Masa · 2025 · Journal of Theoretical Social Psychology
  93. Exploring Treatment Completion and Participant Feedback in an Adapted Intervention among Incarcerated Men with Mental Illness
    Melissa L. Villodas, J Phillips, Ehren Dohler, Anna B. Parisi, Faith Scanlon, Chloe Pilkerton, Amy Blank Wilson · 2025 · Community Mental Health Journal
  94. Violence, Alcohol Use and Schizophrenia Spectrum Disorders: an Overview Across the Lifespan
    Stephanie A. Rolin, Megan G. Flores, Alicia I. Rolin, Mary F. Brunette · 2025 · Current Addiction Reports
  95. Prescription Patterns of Antipsychotics in Schizophrenia: Influence of Symptom Predominance and Clinical Global Impression Scale
    Namita Dash, Indra Lal Sharma, Anusuya Gehlot, Rajkumar Rathore, Ashok Seervi · 2025 · International Journal of Health Sciences and Research
  96. Additional file 1 of Antipsychotic treatment experiences of people with bipolar I disorder: patient perspectives from an online survey
    Leona Bessonova, Dawn I. Velligan, Peter J. Weiden, Amy K. O’Sullivan, Aaron S. Yarlas, Martha S. Bayliss, Nishtha Baranwal, Kaitlin Rychlec, Julia Carpenter-Conlin, Doane, Michael J. et al. · 2020 · Figshare
  97. Additional file 1 of Impact of adverse reactions to first-generation antipsychotics on treatment adherence in outpatients with schizophrenia: a cross-sectional study
    Merhawi Bahta, Azieb Ogbaghebriel, Mulugeta Russom, Tesfamariam, Eyasu H., Tzeggai Berhe · 2021 · Figshare
  98. Additional file 2 of Antipsychotic treatment experiences of people with bipolar I disorder: patient perspectives from an online survey
    Leona Bessonova, Dawn I. Velligan, Peter J. Weiden, O’Sullivan, Amy K., Aaron S. Yarlas, Martha S. Bayliss, Nishtha Baranwal, Kaitlin Rychlec, Julia Carpenter-Conlin, Doane, Michael J. et al. · 2020 · Figshare
  99. Additional file 1 of Peer specialists deliver cognitive behavioral social skills training compared to social skills training and treatment as usual to veterans with serious mental illness: study protocol for a randomized controlled trial
    Chantele Mitchell-Miland, McCarthy, Sharon, Chinman, Matthew · 2022 · Figshare
  100. Additional file 1 of Examining clinician choice to follow-up (or not) on automated notifications of medication non-adherence by clinical decision support systems
    Dan Thorpe, Jörg E. Strobel, Niranjan P. Bidargaddi · 2024 · Figshare